How do you treat a patient with synchronous locally advanced lung and head and neck cancers?
Does the availability of first line checkpoint inhibitor therapy affect your treatment decision?
Answer from: Radiation Oncologist at Academic Institution
This is obviously a very difficult and challenging clinical situation. Most people have a very difficult time undergoing simultaneous treatment to both areas. Typically, I have started with induction systemic therapy. This is especially useful for larynx and hypopharynx cancer patients. This provide...
Answer from: Medical Oncologist at Academic Institution
We currently have no data to support the treatment of oligometastatic disease as we consider treatment for the patient's locally advanced head and neck cancer. With that said, I agree with @Neal E. Dunlap that I would treat both sites with the goal of improving local control of disease, not necessar...